Pharmaceuticals
- Reports
Emirates Pharmaceuticals enhances warehouse efficiency and supports investment with the “warehousing with others” model.
The Emirates Pharmaceutical Corporation announced the implementation of the “Store by Third Party” model – 3PL“For the first time, and…
Read More » - Reports
Emirates Pharmaceuticals discusses with partners and customers the development of marketing approval services for medical devices and equipment
The Emirates Drug Corporation organized a Customer Council, virtually, with the participation of a number of partners and customers in…
Read More » - Reports
Emirates Pharmaceuticals announces the withdrawal of two insecticide products
The Emirates Pharmaceutical Corporation announced the withdrawal of two violating insecticide products bearing the name “Goodbye All Insects“, produced by…
Read More » - Reports
Emirates Pharmaceuticals and Arcera sign a memorandum of understanding to support pharmaceutical manufacturing in the country
The Emirates Pharmaceutical Corporation and Arcera, the global company specialized in the life sciences sector, signed a memorandum of understanding…
Read More » - Reports
Emirates Pharmaceuticals showcases local human pharmaceutical manufacturing during “Made in the UAE 2026”
During its participation in the activities of the “Make in the Emirates 2026” exhibition, which was launched today at the…
Read More » - Reports
Emirates Pharmaceuticals showcases its most prominent initiatives in “Made in the UAE 2026”
During its participation in the “Make in the UAE 2026” exhibition, which kicks off tomorrow at the Abu Dhabi National…
Read More » - Money and business
Pharmaceutical’s profits decreased to 65.1 million riyals in the first quarter of 2026
The profits of the Saudi Pharmaceutical Industries and Medical Supplies Company decreased in the first quarter of 2026 by 8%…
Read More » - Reports
Emirates Pharmaceuticals adopts the first epinephrine nasal spray as an alternative to injections in cases of severe allergies
Today, Wednesday, the Emirates Pharmaceutical Corporation approved “Urnify” nasal spray, which contains the active ingredient epinephrine, in concentrations of 1…
Read More » - Reports
As an alternative to injections, Emirates Pharmaceuticals adopts the Orforgliprone-Fondayo product to treat obesity.
The Emirates Pharmaceutical Corporation has approved the product Orforgliliprone “Fundio™”, which is an innovative oral treatment to reduce weight gain…
Read More » - Reports
Emirates Pharmaceuticals has carried out more than 568 monitoring visits since the beginning of the year
The Emirates Pharmaceutical Corporation has carried out more than 568 inspection visits since the beginning of the year to medical…
Read More »
